🧪Did you know: 1 in 5 people living with #T2D have a degree of #fibrosis? Prof Kenneth Cusi (@UFEndocrinology) urges clinicians to screen for & prevent #MASLD from progressing to cirrhosis #ADAConsensusReport.
📺Watch the latest #ExpertInsights ep now: https://t.co/8vZyITXFyy
✈️ Going away for a holiday?
Having diabetes should not stop you from travelling and enjoying your holiday.
This leaflet provides essential information ⬇️
Take a look here: https://t.co/KoZObGDE9M
🔥 Reversing prediabetes
In a global study of 8,000+ people with prediabetes, returning to normal glucose levels cut risk of developing #T2D by 51% 📉
💪 Add healthy BMI, waist, BP, lipids = up to 80–85% risk reduction!
🏃♀️ Weight loss + normoglycaemia is key
#Prediabetes #Prevention #Diabetes #PublicHealth #Obesity #LifestyleMedicine #Endocrinology #MedTwitter
https://t.co/l85FH3G2ri
@DiannaMagliano et al
🚨 NEW GUIDANCE for CGM use and class 2 drivers 🚗
➡️CGM now safe to use if class 2 drivers ONLY IF approved for non adjunctive use!! ✅
Do use our CGM comparison chart to check which ones will be safe to use here:
🔗 https://t.co/7xrp7qMQL4
We are excited to announce that @parthaskar, the Type 1 Diabetes & Technology Lead for NHS England, will be speaking at our London Discovery Day in September.
Don’t miss out! Sign up for free today ➡️ https://t.co/GHamaimlFm
#T1D#DiscoveryDay#GBDoc
Are you getting ready for your Summer holidays? ☀️
Travelling with diabetes means there are a few extra things to think about before you set off. But living with diabetes shouldn't be a barrier to taking trips✈️
We've put together a handy checklist✅
🔗 https://t.co/ONi2tHHGCL
Diabetes HCPs- share your views on hybrid closed loop rollout.
You can access the survey via the following link:https://t.co/sIKpncO9RT
The survey will be running until midday on 01/08/2025. This is a 15 minute online survey developed as part of a MSc dissertation project.
The JBDS-IP Conference takes place on the 📅 13th June 2025 📍Liverpool.
Learn how to provide an accredited service for inpatient diabetes, apply the latest guidelines, and manage challenges in inpatient diabetes.
Register by 2nd May to save 📝 https://t.co/HRzPm26Uht
Did you know?
There is a comic-book regards #T1Diabetes diagnosis and raising of awareness?
A fun project with @mbrp1 with help from @RevolveComics - it has won multiple awards and had a fair few downloads too!
Have a read, use, RT as you wish #GBDoc
And of course- FREE! @NHSDiabetesProg
Link:
https://t.co/6iERHCyH5h
🗓 Save the Date: Type 2 Diabetes Prevention Week
We’re teaming up with @NHSEngland for this year’s #Type2Diabetes Prevention Week
We'll be raising awareness and sharing advice on how to reduce your risk of developing type 2 diabetes 💙
Find out more 👉 https://t.co/z4ewBCrwqc
We published seven pages dedicated to preoperative optimisation proven to reduce surgical complications by up to 50% for patients.
The pages provide resources for clinicians to support patients to improve their outcomes.
📷View the 7 interventions here: https://t.co/hWdsdh7MTL
Good injection technique ensures that you get the most out of your injectable therapy and achieve the best blood glucose control possible while avoiding complications associated with poor injection technique.
🔗 Visit our dedicated ITM page here: https://t.co/ygdcYv6Lqt
Pancreatic cancer, often linked to smoking, obesity and diabetes, is predicted to become the 2nd leading cause of cancer-related death by 2030.
A recent Seminar discusses the need for novel therapies & future directions for research: https://t.co/IQNCCl8FJY
Do you feel confident counselling patients on GLP1s, their indications and their side effects? Brush up on your weight loss drug knowledge and read this EXCELLENT review article by Dr Lisa Sharkey @lisa_shark, packed with evidence-based insights and expert tips!
🚨 PODCAST COMING SOON 🚨 https://t.co/Wu4QEbAxK2
🤳 First developed as treatments for diabetes, GLP-1 receptor agonists are increasing in popularity for weight loss, thanks in part to social media and celebrity endorsements.
🤢 GI S/Es are common, including nausea, vomiting and constipation.
💊 In the future, there may be expanded indications for use, such as dumping syndrome or chronic diarrhoeal conditions.
@PhilSmithIsBack@OTavabie@dr_aditi_kumar@DrJMKennedy@DunnePdj@TrevorTabone@eathar_s@IrenePerezMD@KGananandan@zare_benjamin@medicalreg@dtleiberman
#WeightLossDrugs #ObesityTreatment #GLP1 #Semaglutide #Tirzepatide #Ozempic #Wegovy #Mounjaro #MetabolicHealth #AntiObesityMedications #MedicalWeightLoss #ObesityMedicine #PharmaObesity #GLP1Agonists #ChronicWeightManagement
A reminder - again- to media colleagues
#Prevention & discussion of that (or 'remission') - When talking in context of #Diabetes- kindly mention Type #T2Diabetes
Why?
Cos otherwise to a child with #T1D who may not understand “context”?
It’s giving false hope
And unfair
Amongst many other things
Thank you